BURLINGAME, Calif.–Sensorin, a privately held company focused on the development and commercialization of a proprietary, novel self-calibrating pH measurement platform for bioprocess and other industrial applications, today announced four key additions to the company’s leadership. Dr. James A. Wilkins has been named Chief Technology Officer and joins Sensorin from Genentech; Dean A. Mansour, P.E., has been named Vice President of Engineering and joins the company from Carl Zeiss Meditec; and Robert W. Carroll has been named Vice President of Operations and Manufacturing and formally joins the company, after serving as a high level advisor. In addition, Robert Sebes, a successful analytical tools serial entrepreneur and investor joins the company’s Board of Directors.

“We are very pleased to welcome four seasoned professionals to the Sensorin team,” said Carolyn R. Kahn, Ph.D., Sensorin Founder, President and Chief Executive Officer. “Jim joins the company with over 25 years of executive experience in biopharmaceutical manufacturing and chemical engineering. Dean has over 20 years of experience in the development and manufacture of leading-edge analytical products, at both large companies and small firms. Bob Carroll has been a senior operations executive at analytical tools corporations that are well established, at companies entering the commercial phase and start-ups for over 25 years. Bob Sebes has been in the industry over 35 years. Their wealth of experience and leadership will be invaluable as we prepare to launch our first product for the biopharmaceutical market in 2010 and begin to address additional market opportunities for our unique sensing technology.”

Jim Wilkins was most recently Director, Technology Assessment and Transfer at Genentech and earlier served as an executive in process development and manufacturing at Alexion Pharmaceutics. He has held biophysics and chemical engineering research faculty positions at Yale University and Johns Hopkins Universities, Jim earned his B.A. from the University of Texas at Austin, holds a Ph.D. in Biochemistry from the University of Tennessee.

Dean Mansour most recently led a team of engineers making sophisticated optical analytic tools for Carl Zeiss Meditec. He directed programs at Laserscope for the GreenLight™ medical laser and its disposable fiber. At Applied Materials Dean worked on electron-beam technology mask pattern generation systems. He led a team at Imatron in a joint development program with Siemens for medical imaging. Dean began his career at the Stanford Linear Accelerator, after earning his BSME at the University of California at Berkeley.

Bob Carroll has consulted to over 20 emerging technology companies over the past eight years. Previously, Bob served as the VP Materials and Manufacturing Operations at Affymetrix, Inc. He joined Affymetrix in its early commercial stage and served through six years of rapid growth and expansion. Prior to that, Bob served at Applied Biosystems as VP Site Operations and grew with it through its acquisition by Perkin Elmer, serving as Director of Worldwide Distribution and Division Vice President. Bob earned his B.S. Electrical Engineering at Case Institute of Technology and a Manufacturing Management program with the General Electric Corporation.

Robert Sebes is a private investor with 30 years experience in forming, operating and transitioning rapid growth analytical instrument businesses. Bob is a partner and serves on the board of a number of small analytical instrument companies. As CEO of SensIR Technologies he led the successful commercialization of the first FT-IR based products for out of lab use. As COO of Spectra-Tech and VP of ASI Applied Systems Bob was instrumental in building the infrastructure to support the rapid growth of both companies. Spectra Tech was sold to Nicolet (now Thermo Fischer Scientific) and ASI was sold to Mettler.

About Sensorin

Sensorin is developing and commercializing a novel, proprietary and versatile sensing technology platform. The company is initially focusing on pH measurement in high-value manufacturing, where an internally referenced, self-calibrating system without drift is advantageous. The Sensorin system is solid state, reliable, accurate and robust for deployment in process applications. The company plans to launch its first commercial pH sensing system for biologics manufacturing in 2010. For more information on Sensorin and its technology, please visit https://www.sensorin.com.